{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:16:33Z","timestamp":1791288993862,"version":"4.3.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cca.2024.119811","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:15:36Z","timestamp":1718298936000},"page":"119811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Computer-assisted patient identification tool in inborn errors of metabolism \u2013 potential for rare disease patient registry and big data analysis"],"prefix":"10.1016","volume":"561","author":[{"given":"Chloe Miu","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline Pao Sun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicite Enyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Chi Hang","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Pui Ying","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Long Fung","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Siu Chun","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby Chun Hei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeow Kuan","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Chun Yiu","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Wan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.119811_b0005","article-title":"Registries: Big data, bigger problems?","author":"Rubinger","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.cca.2024.119811_b0010","series-title":"AHRQ methods for effective health care. In: Registries for evaluating patient outcomes: A user\u2019s guide. Gliklich RE, Dreyer NA","year":"2010"},{"key":"10.1016\/j.cca.2024.119811_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1948","article-title":"The evolution of the population-based cancer registry","volume":"6","author":"Parkin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2024.119811_b0020","unstructured":"Forman D. Cancer incidence in five continents. In: IACR; 2014."},{"key":"10.1016\/j.cca.2024.119811_b0025","series-title":"Overview of Hong Kong cancer statistics of 2020","author":"Registry","year":"2020"},{"key":"10.1016\/j.cca.2024.119811_b0030","series-title":"NIH clinical research trials and you: List of registries","author":"Health","year":"2022"},{"key":"10.1016\/j.cca.2024.119811_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-018-0889-0","article-title":"Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease","volume":"13","author":"Wood","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.47102\/annals-acadmedsg.V38N6p546","article-title":"Development of a diabetes registry to improve quality of care in the National Healthcare Group in Singapore","volume":"38","author":"Toh","year":"2009","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.cca.2024.119811_b0045","first-page":"185","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.cca.2024.119811_b0050","first-page":"359","article-title":"Rare diseases in Europe: from a wide to a local perspective","volume":"18","author":"Baldovino","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.cca.2024.119811_b0055","unstructured":"Administration UFaD. Orphan Drug Act of 1983. In. Edited by Administration UFaD; 1983."},{"key":"10.1016\/j.cca.2024.119811_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5582\/irdr.2022.01034","article-title":"The definition of rare disease in China and its prospects","volume":"11","author":"Lu","year":"2022","journal-title":"Intractable & Rare Diseases Research"},{"key":"10.1016\/j.cca.2024.119811_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5582\/irdr.2019.01066","article-title":"Incidence and prevalence of 121 rare diseases in China: Current status and challenges","volume":"8","author":"He","year":"2019","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.cca.2024.119811_b0070","article-title":"What is a rare disease (the definition of rare diseases in Taiwan)?","author":"MoHaW","year":"2019","journal-title":"In"},{"key":"10.1016\/j.cca.2024.119811_b0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jamiaopen\/ooaa030","article-title":"The case for open science: rare diseases","volume":"3","author":"Rubinstein","year":"2020","journal-title":"JAMIA Open"},{"key":"10.1016\/j.cca.2024.119811_b0080","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The Challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.cca.2024.119811_b0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/21678707.2015.1063415","article-title":"The importance of natural histories for rare diseases","volume":"3","author":"Gavin","year":"2015","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"10.1016\/j.cca.2024.119811_b0090","first-page":"288","article-title":"The current situation and needs of rare disease registries in Europe","volume":"16","author":"Taruscio","year":"2013","journal-title":"Community Genetics"},{"key":"10.1016\/j.cca.2024.119811_b0095","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/humu.23878","article-title":"GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry","volume":"40","author":"Reuser","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2024.119811_b0100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/jimd.12416","article-title":"Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry","volume":"44","author":"Keller","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cca.2024.119811_b0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2020.12.295","article-title":"Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment","volume":"132","author":"Weinreb","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2024.119811_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare disease registries are key to evidence-based personalized medicine: highlighting the European experience","volume":"13","author":"K\u00f6lker","year":"2022","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.cca.2024.119811_b0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1172-9-81","article-title":"The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry","volume":"9","author":"Viviani","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13023-021-02130-7","article-title":"National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses","volume":"16","author":"Guo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0125","series-title":"In","article-title":"Developing a Patient Registry: A Practical Guide","author":"Gardner","year":"2018"},{"key":"10.1016\/j.cca.2024.119811_b0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13023-022-02530-3","article-title":"Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry","volume":"17","author":"Benito-Lozano","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0135","doi-asserted-by":"crossref","first-page":"O7","DOI":"10.1186\/1750-1172-9-S1-O7","article-title":"The French national registry for rare diseases: an integrated model from care to epidemiology and research","volume":"9","author":"Choquet","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0140","first-page":"12","article-title":"A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry","author":"Napier","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0145","unstructured":"Establishment of Hong Kong Neuromuscular Disorder patient registry (HKNMDPR). In: Queen Mary Hospital and Hong Kong Children\u2019s Hospital."},{"key":"10.1016\/j.cca.2024.119811_b0150","unstructured":"[Invitation] Hong Kong NMD Patient Registry. In: Rare Disease Hong Kong; 2019."},{"key":"10.1016\/j.cca.2024.119811_b0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.12809\/hkmj208659","article-title":"Lessons learnt from a genetic disease registry in Hong Kong","volume":"27","author":"Lam","year":"2021","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.cca.2024.119811_b0160","first-page":"14","article-title":"RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework","author":"Bellgard","year":"2019","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.cca.2024.119811_b0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40779-021-00338-z","article-title":"Data mining in clinical big data: the frequently used databases, steps, and methodological models","volume":"8","author":"Wu","year":"2021","journal-title":"Military Medical Research"},{"key":"10.1016\/j.cca.2024.119811_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01831-3","article-title":"How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system","volume":"16","author":"Berger","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0175","first-page":"340","article-title":"Tremblay Volv Global Lausanne Switzerland M. Learning to identify rare disease patients from electronic health records","volume":"2018","author":"Colbaugh","year":"2018","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.cca.2024.119811_b0180","unstructured":"National Rare Disease Registry System of China. In. National Rare Disease Registry System of China; 2023."},{"key":"10.1016\/j.cca.2024.119811_b0185","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2024.119811_b0190","series-title":"The Chief Executive\u2019s 2022 Policy Address","year":"2022"},{"key":"10.1016\/j.cca.2024.119811_b0195","unstructured":"HKHA. Hospital Authority Data Sharing Portal: Data Collaboration Lab. In. Hospital Authority: Data Sharing Portal: Hospital Authority; 2019. https:\/\/www3.ha.org.hk\/data\/DCL."},{"key":"10.1016\/j.cca.2024.119811_b0200","first-page":"260","article-title":"eHealth Record Sharing: enhancing participation for public health surveillance","volume":"18","author":"Cheung","year":"2012","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.cca.2024.119811_b0205","series-title":"StatPearls. Treasure Island (FL): Statpearls Publishing. Copyright \u00a9 2022","article-title":"Inborn errors of metabolism","author":"Jeanmonod","year":"2022"},{"key":"10.1016\/j.cca.2024.119811_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2017.11.002","article-title":"Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management","volume":"65","author":"Saudubray","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.cca.2024.119811_b0215","first-page":"983","article-title":"Analysis of inborn errors of metabolism: disease spectrum for expanded newborn screening in Hong Kong","volume":"124","author":"Lee","year":"2011","journal-title":"Chin Med J (engl)"},{"key":"10.1016\/j.cca.2024.119811_b0220","first-page":"16","article-title":"Evaluation of the 18-month pilot study of newborn screening for inborn errors of metabolism in Hong Kong","volume":"25","author":"Hau","year":"2020","journal-title":"Hong Kong J Paediatr"},{"key":"10.1016\/j.cca.2024.119811_b0225","unstructured":"Hong Kong Hospital Authority. Annual Plan 2022-23. In; 2022 https:\/\/www.ha.org.hk\/haho\/ho\/ap\/AP2223_Eng_1.pdf."},{"key":"10.1016\/j.cca.2024.119811_b0230","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/amiajnl-2011-000535","article-title":"Automated extraction of ejection fraction for quality measurement using regular expressions in Unstructured Information Management Architecture (UIMA) for heart failure","volume":"19","author":"Garvin","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.cca.2024.119811_b0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/jbin.2001.1029","article-title":"A simple algorithm for identifying negated findings and diseases in discharge summaries","volume":"34","author":"Chapman","year":"2001","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cca.2024.119811_b0240","first-page":"46","article-title":"Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network","author":"Salvatore","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.cca.2024.119811_b0245","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/ijerph15081746","article-title":"SpainUDP: the Spanish undiagnosed rare diseases program","volume":"15","author":"L\u00f3pez-Mart\u00edn","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cca.2024.119811_b0250","first-page":"14","article-title":"The Korean undiagnosed diseases program: lessons from a one-year pilot project","author":"Kim","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/archdischild-2020-319180","article-title":"Singapore undiagnosed disease program: genomic analysis aids diagnosis and clinical management","volume":"106","author":"Bhatia","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cca.2024.119811_b0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-022-02365-y","article-title":"Shortcutting the diagnostic odyssey: the multidisciplinary program for undiagnosed rare diseases in adults (UD-PrOZA)","volume":"17","author":"Schuermans","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0265","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of genetic diagnosis on patients with previously undiagnosed disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2024.119811_b0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.31662\/jmaj.2021-0003","article-title":"Initiative on rare and undiagnosed disease in Japan","volume":"4","author":"Takahashi","year":"2021","journal-title":"JMA J"},{"key":"10.1016\/j.cca.2024.119811_b0275","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/ajmg.a.62847","article-title":"Undiagnosed disease program in South Africa: Results from first 100 exomes","volume":"188","author":"Moosa","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cca.2024.119811_b0280","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","article-title":"Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry","volume":"17","author":"Beck","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0285","first-page":"10","article-title":"Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding","author":"Aym\u00e9","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2024.119811_b0290","article-title":"Beijing Medical Association holds an expert seminar on rare disease research projects","author":"Rare Disease Branch BMA","year":"2014","journal-title":"In: Rare Disease Branch"},{"key":"10.1016\/j.cca.2024.119811_b0295","unstructured":"Administration DoM. The fifth session of the 13th National People\u2019s Congress Reply. In; 2023."},{"key":"10.1016\/j.cca.2024.119811_b0300","unstructured":"Artifical Intelligence Innovation Center RIoT, Pearl River Delta. Rare Disease Data Center. In; 2022."},{"key":"10.1016\/j.cca.2024.119811_b0305","doi-asserted-by":"crossref","first-page":"e0216600","DOI":"10.1371\/journal.pone.0216600","article-title":"Facilitating public and patient involvement in basic and preclinical health research","volume":"14","author":"Maccarthy","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2024.119811_b0310","unstructured":"A. KEI Schouten, Briefing Note 2020:4 Selected government definitions of orphan or rare diseases. In, Knowledge Ecology International."},{"key":"10.1016\/j.cca.2024.119811_b0315","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(08)61393-8","article-title":"35 years of Japanese policy on rare diseases","volume":"372","author":"Hayashi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.119811_b0320","unstructured":"Singapore Ministry of Health, Rare disease fund to provide financial support to Singaporeans with rare diseases, In (2019), https:\/\/www.moh.gov.sg\/news-highlights\/details\/rare-disease-fund-to-provide-financial-support-to-singaporeans-with-rare-diseases."},{"key":"10.1016\/j.cca.2024.119811_b0325","unstructured":"Rare disease management Act. In. Korea Legislation Research Institute 2015. https:\/\/elaw.klri.re.kr\/eng_service\/lawView.do?hseq=43655&lang=ENG."},{"key":"10.1016\/j.cca.2024.119811_b0330","article-title":"Suffering in silence: assessing rare disease awareness and management in Asia-Pacific. In","author":"Elliott","year":"2020","journal-title":"The Economist: Intelligence Unit"},{"key":"10.1016\/j.cca.2024.119811_b0335","series-title":"Orphan drug designation eligibility criteria","year":"2018"},{"key":"10.1016\/j.cca.2024.119811_b0340","unstructured":"The UK Rare Diseases Framework. In. GOV.UK: Department of Health & Social Care; 2021. https:\/\/www.gov.uk\/government\/publications\/uk-rare-diseases-framework."},{"key":"10.1016\/j.cca.2024.119811_b0345","unstructured":"Rare Disease Act of 2002. In. Edited by Congress US; 2002. https:\/\/www.congress.gov\/107\/plaws\/publ280\/PLAW-107publ280.pdf."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T11:43:12Z","timestamp":1720957392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124020631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":69,"alternative-id":["S0009898124020631"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119811","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computer-assisted patient identification tool in inborn errors of metabolism \u2013 potential for rare disease patient registry and big data analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119811"}}